Q2 FY27 Earnings: 10 Stocks That Could See Action in November
Last Updated: 18th November 2026 - 06:35 pm
The Q2 FY27 results cover July to September 2026, but a company’s earnings announcement is only the beginning of the market’s reassessment. By mid-November, most major results were already public. The immediate surprise has therefore shifted towards management commentary, monthly business updates, commodity prices, global demand, and whether the stock can sustain its reaction to the numbers.
A rise in revenue is not sufficient to establish stronger earnings. A company can sell more while earning less on every unit if raw materials, employee expenses, or financing costs rise. Conversely, a subdued quarter can hide improving orders, customer additions, or product mix. The useful November watchlist is built around that distinction, rather than treating every double-digit revenue increase as equally positive. Rounding is used in this summary. NIM is net interest margin; CC means constant currency; TCV is total contract value. Sources appear at the end of this document.
1. Tata Consultancy Services: AI Demand Versus Revenue Conversion
TCS reported September-quarter revenue of USD 9.6 billion. Annualised AI revenue rose to US$3.1 billion and accounted for more than 10% of revenue. BFSI, manufacturing, and technology services performed better than some consumer-oriented verticals.
The November question is whether a healthy deal pipeline can drive faster organic revenue growth without diluting profitability. Investors will also examine hiring, subcontractor costs, and the sustainability of the reported AI run-rate. A renewed slowdown in global discretionary technology spending or a weak conversion of large contracts could generate volatility even if order wins remain strong.
2. Infosys: Stable Margins but a Narrower Revenue Outlook
Infosys recorded Q2 FY27 revenue of ₹49,244 crore, up 10.7% year on year in rupee terms, while operating margin remained at 21.0%. Large deal TCV was US$5.2 billion. The company revised its FY27 constant-currency revenue growth guidance to 1–2% and retained its operating margin guidance of 20–22%. These numbers capture a business maintaining profitability while still facing restrained underlying demand.
Attention now turns to the timing of large-deal revenue recognition, client spending in North America and Europe, and whether AI-led programmes add meaningful incremental business. An improvement in deal execution without wage or delivery-cost pressure would support earnings confidence; continued slow client decisions could weigh on the outlook. The guidance range is management’s stated expectation, not a forecast of the stock price.
3. ICICI Bank: Loan Growth Faces a Margin Test
ICICI Bank’s net interest income rose 17.7% year on year to ₹25,339 crore, with standalone profit after tax of ₹14,843 crore, up 20.1%. Yet net interest margin declined to 4.18% from 4.36% in the preceding quarter. Gross non-performing assets improved to 1.20% from 1.38% in June. Deposit growth was also strong, although the reported headline includes foreign-currency non-resident deposits.
The key issue is the balance between advances growth and the cost of attracting deposits. Investors should track normalised deposit growth, loan yields, fee income and credit costs rather than treat loan growth alone as proof of improving returns. Faster funding costs or a return of slippages would create downside risk; improved funding mix and stable asset quality could support sentiment.
4. State Bank of India: Improving Credit Quality and Deposit Costs
SBI reported Q2 FY27 net profit of ₹23,038 crore, up 14.28% year on year, while net interest income increased 14.69%. Domestic net interest margin reached 3.11%, improving by 11 basis points over the June quarter. The gross NPA ratio improved to 1.39% and the net NPA ratio to 0.36%. Whole-bank advances increased 17.84% year on year, ahead of deposit growth of 12.27%.
That gap between credit and deposit growth makes deposit mobilisation a key variable for November. Stronger lending and lower credit costs are encouraging, but expanding the loan book faster than liabilities can eventually affect funding expense. Investors will look for evidence that margins can hold without sacrificing growth or asset quality. Its public-sector banking exposure also makes broader rate and bond-market movements relevant.
5. Reliance Industries: Record EBITDA Masks Divergent Segments
Reliance Industries posted Q2 FY27 gross revenue of ₹3,62,268 crore, up 27.8%, and EBITDA of ₹62,409 crore, up 23.9%. Consolidated EBITDA margin nevertheless declined to 17.2% from 17.8% a year earlier. The oil-to-chemicals division benefited from stronger fuel and petrochemical margins, while digital services remained resilient. Retail EBITDA declined 8.6% year on year as investment, input costs and the festive calendar affected performance.
The market will watch how much of the energy-led earnings boost proves repeatable and whether retail profitability recovers in the December quarter. Jio Platforms’ October stock-market debut also changes the way investors may assess the group’s consumer and energy businesses. Crude-price volatility, refining spreads, capital expenditure and the value attributed to its listed digital subsidiary are potential drivers of share-price swings.
6. Mahindra & Mahindra: SUVs Grow, Farm Margins Soften
M&M delivered Q2 FY27 consolidated revenue of ₹57,553 crore, up 25%, and profit after tax of ₹4,588 crore, also up 25%. Automobile volumes increased, with SUV revenue market share at 24.3%. However, its standalone auto profit-before-interest-and-tax margin was 7.7%, or 9.1% excluding the electric-SUV contract manufacturing arrangement. The farm business faced softer revenue and lower profitability during a festive-season shift.
For November, the relevant test is whether strong utility-vehicle demand can translate into better realised margins as model mix changes and electric-vehicle investments continue. Tractor demand, farm profitability and raw-material costs will influence the overall group picture. Investors should distinguish a rise in automobile sales from the margins earned on those sales, especially during launches and expansion periods.
7. Maruti Suzuki: Record Volumes, But Profit Pressure
Maruti Suzuki reported record quarterly vehicle sales of 6,96,654 units, up 26.5%, and net sales of ₹50,615.5 crore. Yet operating profit fell to ₹2,803.7 crore from ₹3,382.0 crore a year earlier, partly because of higher commodity expenses. Net profit dropped to ₹2,414.9 crore from ₹3,302.8 crore, with lower non-operating income also affecting the comparison. This was a clear case where higher volumes did not produce higher earnings.
November attention is likely to centre on festive retail demand, product mix, discounting and the ability to recover inflation in materials through pricing. The company reported approximately 17 days of dealer inventory at September-end and about 2,00,000 pending bookings. Strong bookings are supportive, but any sustained raw-material inflation or weak price increases could continue to pressure profit conversion.
8. Bharti Airtel: ARPU Gains Against Heavy Network Investment
Bharti Airtel’s Q2 FY27 consolidated revenue increased 16.7% year on year to ₹60,878 crore. EBITDA reached ₹35,240 crore, representing a 57.9% margin. India mobile average revenue per user improved to ₹271 from ₹256 a year earlier. The operator also reported record quarterly postpaid net additions of 1.2 million customers, while consolidated capital expenditure stood at ₹12,467 crore.
The watchpoint is whether improving customer mix, higher data usage and home broadband growth continue to outpace the cost of network rollout. Capex, spectrum liabilities and competition can influence cash generation even when EBITDA is rising. Sustained premiumisation would reinforce the earnings narrative; slower tariff realisation or renewed network costs could cause volatility. Subscriber trends matter more than a single quarter’s profit figure.
9. Sun Pharma: The Difference Between Adjusted and Reported Earnings
Sun Pharma reported Q2 FY27 sales of ₹16,100 crore, up 11.8% year on year, and EBITDA of ₹4,743.9 crore, up 4.8%, giving an EBITDA margin of 29.3%. Reported net profit stood at ₹1,988.5 crore, whereas adjusted net profit was ₹3,162 crore. India formulations sales increased 17.3%, but US formulations sales fell 8.2% in dollar terms. Global innovative medicines sales grew 6.9%.
The large gap between adjusted and reported profit deserves as much attention as revenue growth. Investors should examine exceptional-item disclosures, US product concentration, research spending, and the planned Organon acquisition integration. Progress on innovative-medicine launches could strengthen the long-term growth case, while regulatory costs, weak US generics, or acquisition-related expenses may keep headline earnings volatile.
10. Larsen & Toubro: A Record Order Book Meets Margin Headwinds
L&T reported approximately ₹1.48 lakh crore of new orders in Q2 FY27, up 28% year on year, and an order book of about ₹8.54 lakh crore at September-end. Revenue stood at roughly ₹78,750 crore, while the group’s EBITDA margin excluding other income was 8.7%, compared with 10.0% a year earlier. Management attributed the margin decline to project mix and cost pressure, including water and effluent-treatment work.
The central November question is how quickly this unusually large order pipeline turns into profitable revenue and cash. The international order mix provides scale but adds execution, logistics, and geopolitical exposure. Progress on working-capital release and margins in newer projects will be important. Investors may reward further order wins, but an elevated order book alone does not guarantee stronger earnings per share.
What Could Trigger Volatility After the Results?
Three areas deserve particular attention in the weeks after earnings. First is earnings quality: reported profit may be distorted by exceptional items, investment income, or treasury movements. Second is margin direction: sequential and year-on-year changes can tell different stories, as seen in automobiles, banks, and capital goods. Third is forward visibility: order wins, guidance ranges, customer additions, and management comments can matter more than the latest quarter’s revenue number.
These stocks also respond to different external influences. Currency and overseas technology budgets affect IT; deposit pricing and rates affect banks; commodity costs and consumer demand affect automobiles; crude and refining margins affect Reliance; and project execution affects L&T. Tracking these factors alongside price and trading volume offers a stronger basis for assessing reactions than assuming that a good earnings headline automatically means a good investment.
Conclusion
Q2 FY27 shows why November’s watchlist cannot be reduced to the companies reporting the fastest sales growth. TCS and Infosys have maintained important operating metrics despite uneven global demand. ICICI Bank and SBI show loan growth with different margin dynamics. M&M is benefiting from SUV demand, while Maruti shows how costs can overwhelm stronger volumes. Airtel’s higher customer realisation, Sun Pharma’s reported-versus-adjusted profit difference, Reliance’s divergent segment performance and L&T’s order-to-margin equation add further dimensions.
The next market moves will depend on what changes after these results: management execution, November operating data, input prices, rates, and the durability of earnings. These 10 companies are stocks to monitor, not a ranked buy list or a guarantee of positive returns. A disciplined assessment should compare the current valuation with sustainable earnings and the risks still unresolved.
- Flat ₹20 Brokerage
- Next-gen Trading
- Advanced Charting
- Actionable Ideas
Trending on 5paisa
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.